MD2851G2 - Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer - Google Patents
Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimerInfo
- Publication number
- MD2851G2 MD2851G2 MDA20040199A MD20040199A MD2851G2 MD 2851 G2 MD2851 G2 MD 2851G2 MD A20040199 A MDA20040199 A MD A20040199A MD 20040199 A MD20040199 A MD 20040199A MD 2851 G2 MD2851 G2 MD 2851G2
- Authority
- MD
- Moldova
- Prior art keywords
- aqua
- cobalt
- bis
- inhibitor
- myeloid leukemia
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the application of coordinative combinations in medicine, namely to the use of monohydrate (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt as inhibitor of human myeloid leukemia.Summary of the invention consists in that as inhibitor of human myeloid leukemia is claimed (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt monohydrate of the formula:The result of the invention consists in the establishment at the known (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloro-acetato)cobalt monohydrate of the anticancer activity, exceeding 1,25…1,35 times the analogous characteristics of the dimeric trihydrate of aquaethylene-diaminetetraacetatobismuthate (III) of 1,6-dimitrotetraaminecobalt (III) and dehydrate of ethylenediaminetetraacetatobismuthate (III) of oxalatotetraaminecobalt (III) (of the analogue).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20040199A MD2851G2 (en) | 2004-08-12 | 2004-08-12 | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20040199A MD2851G2 (en) | 2004-08-12 | 2004-08-12 | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2851F1 MD2851F1 (en) | 2005-09-30 |
MD2851G2 true MD2851G2 (en) | 2006-04-30 |
Family
ID=35057542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20040199A MD2851G2 (en) | 2004-08-12 | 2004-08-12 | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2851G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3098G2 (en) * | 2006-01-03 | 2007-02-28 | Государственный Университет Молд0 | Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2786G2 (en) * | 2004-05-11 | 2006-02-28 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III) |
-
2004
- 2004-08-12 MD MDA20040199A patent/MD2851G2/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2786G2 (en) * | 2004-05-11 | 2006-02-28 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
Also Published As
Publication number | Publication date |
---|---|
MD2851F1 (en) | 2005-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20043322B (en) | C7 Ester Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof for Inhibiting Tumors | |
CA2463294A1 (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
UA74443C2 (en) | 5-HT receptor ligands and their use | |
YU4602A (en) | Preserved pharmaceutical formulations | |
EP2223922A3 (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
PL1791532T3 (en) | Composition in micro-pellets with controlled release of physiologically active substances, procedure for their preparation and use in the zootechnical sector | |
GB2420559B (en) | Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses | |
MY140398A (en) | 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES | |
HRP20080689T3 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
MX2007003013A (en) | Bicyclic amides as kinase inhibitors. | |
EP2014669A3 (en) | Compositions and methods for cancer | |
GEP20094844B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
EP1962843A4 (en) | Use of parp-1 inhibitors | |
EP2392322A3 (en) | Dosing regimes for trans-clomiphene | |
EP1623985A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents | |
GEP20094843B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
MXPA06003222A (en) | Antimutor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor. | |
WO2003106384A3 (en) | Novel boronic chalcone derivatives and uses thereof | |
IL159993A0 (en) | Platinum complexes and their use in cancer treatment | |
MD2851G2 (en) | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer | |
PT1718651E (en) | 7h-pyrrolopyrimidine derivatives | |
TW200504042A (en) | Combretastatin derivatives with cytotoxic action | |
MXPA04001655A (en) | Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof. | |
AU2003271807A8 (en) | Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same | |
ATE491695T1 (en) | TRICYLIC 1,2,4-TRIAZINE OXIDES AND COMPOSITIONS THEREOF FOR THERAPEUTIC USE IN CANCER TREATMENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |